Paul Schmidt
Net worth: 3 912 $ as of 2024-04-29
Profile
Paul Schmidt served as the Chief Executive Officer & Executive Director at Plant Health Care Plc from 2015 to 2016.
Prior to that, he worked at Alberta Innovates BioSolutions as a Director.
Schmidt received his undergraduate and graduate degrees from the University of Saskatchewan in 1980.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PLANT HEALTH CARE PLC
0.02% | 2024-02-29 | 82,000 ( 0.02% ) | 3 912 $ | 2024-04-29 |
Former positions of Paul Schmidt
| Companies | Position | End |
|---|---|---|
| PLANT HEALTH CARE PLC | Chief Executive Officer | 2016-11-29 |
Alberta Innovates BioSolutions
 Alberta Innovates BioSolutions BiotechnologyHealth Technology Alberta Innovates BioSolutions develops bioindustrial technologies and natural products. It delivers on the potential of agriculture and forestry in areas such as: value chain sustainability, advancing the biorefinery, quality food for health, industry challenges and emerging opportunities, and prion and prion-like protein misfolding diseases. The firm aims to be a global gateway and resource for bio-based research, talent, investment and solutions. The company was founded on January 1, 2010 and is headquartered in Edmonton, Canada. | Director/Board Member | - |
Training of Paul Schmidt
| University of Saskatchewan | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PLANT HEALTH CARE PLC | Process Industries |
| Private companies | 1 |
|---|---|
Alberta Innovates BioSolutions
Alberta Innovates BioSolutions BiotechnologyHealth Technology Alberta Innovates BioSolutions develops bioindustrial technologies and natural products. It delivers on the potential of agriculture and forestry in areas such as: value chain sustainability, advancing the biorefinery, quality food for health, industry challenges and emerging opportunities, and prion and prion-like protein misfolding diseases. The firm aims to be a global gateway and resource for bio-based research, talent, investment and solutions. The company was founded on January 1, 2010 and is headquartered in Edmonton, Canada. | Health Technology |
- Stock Market
- Insiders
- Paul Schmidt